Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

PAVmed (PAVM) FCF Margin (2021 - 2025)

PAVmed has reported FCF Margin over the past 5 years, most recently at 1876.54% for Q4 2025.

  • Quarterly results put FCF Margin at 1876.54% for Q4 2025, down 277654.0% from a year ago — trailing twelve months through Dec 2025 was 5237.0% (down 400038.0% YoY), and the annual figure for FY2025 was 5237.0%, down 411483.0%.
  • FCF Margin for Q4 2025 was 1876.54% at PAVmed, up from 18060.0% in the prior quarter.
  • Over the last five years, FCF Margin for PAVM hit a ceiling of 230100.0% in Q1 2021 and a floor of 25864.47% in Q3 2022.
  • Median FCF Margin over the past 5 years was 4026.5% (2021), compared with a mean of 5675.31%.
  • Biggest five-year swings in FCF Margin: tumbled -23689206bps in 2022 and later soared 2446030bps in 2023.
  • PAVmed's FCF Margin stood at 6018.0% in 2021, then plummeted by -154bps to 15286.61% in 2022, then soared by 92bps to 1149.38% in 2023, then soared by 178bps to 900.0% in 2024, then plummeted by -309bps to 1876.54% in 2025.
  • The last three reported values for FCF Margin were 1876.54% (Q4 2025), 18060.0% (Q3 2025), and 20133.33% (Q2 2025) per Business Quant data.